Cholecystokinin-2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma - Results of the Lumed Phase 0a Study
dc.contributor.author
Rottenburger, Christof
dc.contributor.author
Nicolas, Guillaume P.
dc.contributor.author
McDougall, Lisa
dc.contributor.author
Kaul, Felix
dc.contributor.author
Cachovan, Michal
dc.contributor.author
Vija, A. Hans
dc.contributor.author
Schibli, Roger
dc.contributor.author
Geistlich, Susanne
dc.contributor.author
Schumann, Anne
dc.contributor.author
Rau, Tilman
dc.contributor.author
Glatz, Katharina
dc.contributor.author
Behe, Martin
dc.contributor.author
Christ, Emanuel R.
dc.contributor.author
Wild, Damian
dc.date.accessioned
2020-04-22T14:58:03Z
dc.date.available
2020-01-20T16:21:45Z
dc.date.available
2020-01-27T15:58:08Z
dc.date.available
2020-04-22T14:58:03Z
dc.date.issued
2020-04
dc.identifier.issn
0097-9058
dc.identifier.issn
0022-3123
dc.identifier.issn
0161-5505
dc.identifier.issn
2159-662X
dc.identifier.issn
1535-5667
dc.identifier.other
10.2967/jnumed.119.233031
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/392329
dc.language.iso
en
en_US
dc.publisher
Society of Nuclear Medicine
en_US
dc.subject
cholecystokinin 2 receptor targeting
en_US
dc.subject
peptide receptorradionuclide therapy
en_US
dc.subject
177Lu-PP-F11N
en_US
dc.subject
theranostics
en_US
dc.title
Cholecystokinin-2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma - Results of the Lumed Phase 0a Study
en_US
dc.type
Journal Article
dc.date.published
2019-09-13
ethz.journal.title
The Journal of Nuclear Medicine
ethz.journal.volume
61
en_US
ethz.journal.issue
4
en_US
ethz.journal.abbreviated
J Nucl Med
ethz.pages.start
520
en_US
ethz.pages.end
526
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
New York, NY
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03688 - Schibli, Roger / Schibli, Roger
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03688 - Schibli, Roger / Schibli, Roger
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03688 - Schibli, Roger / Schibli, Roger
en_US
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03688 - Schibli, Roger / Schibli, Roger
ethz.date.deposited
2020-01-20T16:21:52Z
ethz.source
FORM
ethz.eth
yes
en_US
ethz.availability
Metadata only
en_US
ethz.rosetta.installDate
2020-04-22T14:58:13Z
ethz.rosetta.lastUpdated
2023-02-06T18:34:09Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Cholecystokinin-2%20Receptor%20Agonist%20177Lu-PP-F11N%20for%20Radionuclide%20Therapy%20of%20Medullary%20Thyroid%20Carcinoma%20-%20Results%20of%20the%20Lumed%20Phase%200&rft.jtitle=The%20Journal%20of%20Nuclear%20Medicine&rft.date=2020-04&rft.volume=61&rft.issue=4&rft.spage=520&rft.epage=526&rft.issn=0097-9058&0022-3123&0161-5505&2159-662X&1535-5667&rft.au=Rottenburger,%20Christof&Nicolas,%20Guillaume%20P.&McDougall,%20Lisa&Kaul,%20Felix&Cachovan,%20Michal&rft.genre=article&rft_id=info:doi/10.2967/jnumed.119.233031&
Files in this item
| Files | Size | Format | Open in viewer |
|---|---|---|---|
|
There are no files associated with this item. |
|||
Publication type
-
Journal Article [131761]